Adam Hanina is the CEO of AiCure, an NIH-funded and venture-backed company that has developed artificial intelligence to visually confirm medication ingestion by clinical trial participants and high-risk patients in real time. He is a passionate advocate for the use of healthcare software as a population health tool and has directed much of his previous work to this end.

Prior to AiCure, Mr. Hanina was responsible for further developing Cerner Corporation’s European strategy and was a Visiting Fellow of eHealth at Imperial College in London, UK. Mr. Hanina has spoken extensively on the topic of healthcare innovation and has held numerous advisory board positions. He holds over 15 patents and has acted as a subject-matter expert on medication adherence technologies for the National Institutes of Health (NIH). He has an MBA from the Wharton School of Business.